Currency In USD
| Previous Close | 18.41 |
| Open | 18.28 |
| Day High | 18.71 |
| Day Low | 18.02 |
| 52-Week High | 21.27 |
| 52-Week Low | 5.95 |
| Volume | 809,365.45 |
| Average Volume | 2.76M |
| Market Cap | 4.02B |
| PE | -11.7 |
| EPS | -1.57 |
| Moving Average 50 Days | 18.73 |
| Moving Average 200 Days | 14.62 |
| Change | -0.05 |
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March
GlobeNewswire Inc.
Feb 23, 2026 9:05 PM GMT
CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic dise
Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026
GlobeNewswire Inc.
Feb 19, 2026 10:55 PM GMT
CAMBRIDGE, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic dise
Relay Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
GlobeNewswire Inc.
Feb 04, 2026 9:05 PM GMT
CAMBRIDGE, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic dise